a also seem to be vanishing. Fewer chromosomes have tested positive for the Philadelphia chromosome that identifies those with CML (Terwilleger 1-3). These great testimonies show how affective STI-571 has already been and hopefully provides a great hope for the advancement of CML treatment.The best way to assess the effect of cancer treatment over the last 25 years is to look at survival data. Whereas for some cancers earlier diagnosis, for instance, via a screening programme, could impact survival figures, development of successful systematic therapy and the improved outcomes for many common cancers can cause and effect. According to the article “One-Hundred Percent Success for Leukemia Drug” published on BBC News Online the current methods of cancer treatment has appeared to increase overall survival, however, these methods have not stop the growth of cancer. Between an average of five years the overall survival rate for men with chronic myeloid leukemia has increased about 10%, while women have increased about 13%. These statistics both show a great increase in the scientific success of cancer treatment however science has not stopped working to destroy this rapidly growing disease. BBC News states that the drug STI-571 could be the “cure” that scientists have been searching for. STI-571 is a drug that is still experimental however its support among pharmaceutical companies and the optimistic outlook created by scientists, doctors, and patients make many feel that STI-571 is the solution to CML (One-Hundred Percent 2). Author Seppa in Science News shows how individual doctors feel about STI-571. Dr. John Groffen, a molecular biologist at the Children’s Hospital and the University of Southern California, both in Los Angeles said “CML is one of the best-known types of cancer. It was inevitable that scientists discover a cure for total remission.” Groffen also states that the use o...
